Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A49458 | 35745091 | Nutrients | Metabolic Dysfunction-Associated Fatty Liver Disease Is Associated with the Risk of Incident Cardiovascular Disease: A Prospective Cohort Study in Xinjiang. | 2022 | Details |
| A49482 | 35740267 | Biomedicines | Combined Effects of Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease on the Risk of Cardiovascular Disease in Patients with Diabetes. | 2022 | Details |
| A49488 | 35739957 | Antioxidants (Basel) | Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. | 2022 | Details |
| A49500 | 35735979 | Hepatology | Apolipoprotein F Is Reduced in Humans with Steatosis and Controls Plasma Triglyceride-Rich Lipoprotein Metabolism. | 2022 | Details |
| A49502 | 35734974 | J Cell Mol Med | A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic fatty liver disease. | 2022 | Details |
| A49511 | 35730209 | Clin Mol Hepatol | Does non-alcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke? | 2022 | Details |
| A49514 | 35728963 | Cas Lek Cesk | Statins and liver. | 2022 | Details |
| A49522 | 35727319 | Eur Radiol | Plaque progression at coronary CT angiography links non-alcoholic fatty liver disease and cardiovascular events: a prospective single-center study. | 2022 | Details |
| A49535 | 35723012 | Scand J Gastroenterol | Validity of fatty liver disease indices in the presence of alcohol consumption. | 2022 | Details |
| A49539 | 35721296 | World J Hepatol | Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2022 | Details |
| A49549 | 35718233 | Life Sci | Physical exercise and the functions of microRNAs. | 2022 | Details |
| A49570 | 35710086 | Ann Hepatol | African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population. | 2022 | Details |
| A49577 | 35708630 | J Med Food | Nil-Surin Rice Bran Hydrolysates Improve Lipid Metabolism and Hepatic Steatosis by Regulating Secretion of Adipokines and Expression of Lipid-Metabolism Genes. | 2022 | Details |
| A49579 | 35708049 | Crit Rev Food Sci Nutr | Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review. | 2022 | Details |
| A49585 | 35702845 | J Assoc Physicians India | Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. | 2022 | Details |
| A49589 | 35701716 | Hepatol Int | A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population. | 2022 | Details |
| A49595 | 35697165 | Int J Biol Macromol | Extraction, purification, structural characterization, and gut microbiota relationship of polysaccharides: A review. | 2022 | Details |
| A49612 | 35692179 | Obes Rev | Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques. | 2022 | Details |
| A49624 | 35688226 | J Hepatol | LIVER STIFFNESS, BUT NOT FATTY LIVER DISEASE, IS ASSOCIATED WITH ATRIAL FIBRILLATION: THE ROTTERDAM STUDY. | 2022 | Details |
| A49659 | 35677507 | J Clin Exp Hepatol | Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India. | 2021 | Details |
| A49663 | 35677499 | J Clin Exp Hepatol | Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis. | 2021 | Details |
| A49666 | 35677024 | Front Oral Health | Does Oral Endotoxin Contribute to Systemic Inflammation? | 2022 | Details |
| A49669 | 35675800 | Cell Metab | Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia. | 2022 | Details |
| A49681 | 35672527 | Heart Vessels | Prognostic value of pericoronary adipose tissue attenuation in patients with non-alcoholic fatty liver disease with suspected coronary artery disease. | 2022 | Details |
| A49712 | 35661987 | Hormones (Athens) | Non-invasive diagnosis and staging of non-alcoholic fatty liver disease. | 2022 | Details |
| A49714 | 35661191 | Aliment Pharmacol Ther | Review article: vascular effects of PPARs in the context of NASH. | 2022 | Details |
| A49719 | 35659558 | BMC Cardiovasc Disord | The correlation of atherosclerosis and triglyceride glucose index: a secondary analysis of a national cross-sectional study of Japanese. | 2022 | Details |
| A49730 | 35655216 | Lipids Health Dis | Association between hypertriglyceridemic-waist phenotype and non-alcoholic fatty liver disease: a general population-based study. | 2022 | Details |
| A49742 | 35651978 | Front Endocrinol (Lausanne) | Non-alcoholic Fatty Liver Disease Is Associated With Aortic Calcification: A Cohort Study With Propensity Score Matching. | 2022 | Details |
| A49745 | 35651599 | Psoriasis (Auckl) | Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management. | 2022 | Details |
| A49753 | 35647047 | Front Cardiovasc Med | Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort. | 2022 | Details |
| A49754 | 35646540 | Acta Pharm Sin B | Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. | 2021 | Details |
| A49769 | 35643414 | Clin Gastroenterol Hepatol | Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality. | 2022 | Details |
| A49778 | 35640037 | Hum Reprod | Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort. | 2022 | Details |
| A49779 | 35639744 | PLoS One | A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis. | 2022 | Details |
| A49789 | 35636583 | Metabolism | Association of fatty liver index with all-cause and disease-specific mortality: A nationwide cohort study. | 2022 | Details |
| A49812 | 35629938 | Metabolites | Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability. | 2022 | Details |
| A49814 | 35629385 | Life (Basel) | Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2022 | Details |
| A49816 | 35628989 | J Clin Med | Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography. | 2022 | Details |
| A49817 | 35628964 | J Clin Med | Association of Oxidized Low-Density Lipoprotein in Nonalcoholic Fatty Liver Disease with High-Risk Plaque on Coronary Computed Tomography Angiography: A Matched Case-Control Study. | 2022 | Details |
| A49844 | 35623903 | Phytother Res | Zingiberaceae plants/curcumin consumption and multiple health outcomes: An umbrella review of systematic reviews and meta-analyses of randomized controlled trials in humans. | 2022 | Details |
| A49854 | 35618017 | Metabolism | Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study. | 2022 | Details |
| A49865 | 35614896 | Visc Med | Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review. | 2021 | Details |
| A49867 | 35614469 | Cardiovasc Diabetol | The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management. | 2022 | Details |
| A49886 | 35608296 | Clin Transl Gastroenterol | The ability of lipoprotein (a) level to predict early carotid atherosclerosis is impaired in patients with advanced liver fibrosis related to metabolic associated fatty liver disease. | 2022 | Details |
| A49889 | 35606076 | Atherosclerosis | Non-genetic influences on lipoprotein(a) concentrations. | 2022 | Details |
| A49906 | 35601123 | JGH Open | Relationship between the prevalence and severity of non-alcoholic fatty liver disease and coronary artery disease: Findings from a cross-sectional study of a referral center in northeast Iran. | 2022 | Details |
| A49917 | 35597274 | Metabolism | Epitranscriptomic challenges and promises in metabolic diseases. | 2022 | Details |
| A49946 | 35585687 | Clin Mol Hepatol | The Effect of Diabetes and Prediabetes on the Prevalence, Complications and Mortality in Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A49962 | 35581956 | Hepatol Commun | Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study. | 2022 | Details |
| A49965 | 35579800 | Dig Dis Sci | MAFLD Versus NAFLD: Which Better Predicts the Risk of Atherosclerotic Cardiovascular Disease? | 2022 | Details |
| A49966 | 35579799 | Dig Dis Sci | MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups. | 2022 | Details |
| A49985 | 35571881 | Front Nutr | Effect of a High Protein, Low Glycemic Index Dietary Intervention on Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial. | 2022 | Details |
| A49988 | 35569886 | Endocr Pract | American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). | 2022 | Details |
| A49993 | 35568374 | Biochim Biophys Acta Mol Cell Biol Lipids | Implications of microbe-mediated crosstalk in the gut: Impact on metabolic diseases. | 2022 | Details |
| A49997 | 35567872 | Complement Ther Clin Pract | The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial. | 2022 | Details |
| A50012 | 35563591 | Int J Mol Sci | Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model. | 2022 | Details |
| A50031 | 35557545 | Front Cardiovasc Med | Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study. | 2022 | Details |
| A50045 | 35547362 | PPAR Res | Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPARγ2 Associated with Type 2 Diabetes, Cardiovascular Disease, and Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50053 | 35545437 | Clin Mol Hepatol | NAFLD versus MAFLD: Prevalence, Outcomes and Implications of a Change in Name. | 2022 | Details |
| A50055 | 35543890 | Obes Surg | Roux-en-Y Gastric Bypass as a Treatment for Hepatic Iron Overload: An Exploratory Study. | 2022 | Details |
| A50062 | 35538431 | BMC Cardiovasc Disord | Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial. | 2022 | Details |
| A50087 | 35532850 | Hormones (Athens) | Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease. | 2022 | Details |
| A50096 | 35528987 | J Clin Transl Hepatol | Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. | 2022 | Details |
| A50099 | 35528971 | J Clin Transl Hepatol | Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. | 2021 | Details |
| A50114 | 35518363 | Cureus | Whether Screening for Non-alcoholic Fatty Liver Disease in Patients With Psoriasis Is Necessary: A Pilot Quality Improvement Project. | 2022 | Details |
| A50117 | 35516713 | J Family Med Prim Care | Evaluation of lipoprotein (a) [Lp(a)] and lipid abnormalities in patients with newly detected hypertension and its association with severity of hypertension. | 2022 | Details |
| A50123 | 35512974 | Fertil Steril | Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome. | 2022 | Details |
| A50124 | 35511653 | Minerva Gastroenterol (Torino) | Treatment with phosphatidylcholine of patients with non-alcoholic fatty liver disease: a prospective pilot study. | 2022 | Details |
| A50132 | 35508444 | Eur J Intern Med | Uric acid in metabolic syndrome: Does uric acid have a definitive role? | 2022 | Details |
| A50136 | 35507280 | Curr Atheroscler Rep | Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease. | 2022 | Details |
| A50137 | 35507279 | Curr Atheroscler Rep | Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50139 | 35506136 | Radiol Cardiothorac Imaging | Hepatosteatosis and Atherosclerotic Plaque at Coronary CT Angiography. | 2022 | Details |
| A50142 | 35504171 | Clin Nutr | Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study. | 2022 | Details |
| A50152 | 35501558 | Curr Obes Rep | Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50156 | 35501169 | Pathology | Design and validation of an LC-MS/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma. | 2022 | Details |
| A50166 | 35494531 | Diabetes Metab Syndr Obes | Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. | 2022 | Details |
| A50184 | 35485970 | Eur J Neurol | Liver Fibrosis-4 index indicates atrial fibrillation in acute ischemic stroke. | 2022 | Details |
| A50186 | 35485357 | J Physiol Pharmacol | Very low-volume interval training improves nonalcoholic fatty liver disease fibrosis score and cardiometabolic health in adults with obesity and metabolic syndrome. | 2022 | Details |
| A50201 | 35478356 | Hepatol Commun | Serum Mac-2 binding protein level predicts the development of liver-related events and colorectal cancer in patients with NAFLD. | 2022 | Details |
| A50204 | 35476909 | Angiology | Atherosclerosis and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50221 | 35467297 | Clin Drug Investig | General Overview About the Current Management of Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50223 | 35465684 | Hypertension | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors. | 2022 | Details |
| A50247 | 35459338 | Klin Onkol | Metabolic syndrome in long-term survivors after allogeneic hematopoietic stem cell transplantation. | 2022 | Details |
| A50248 | 35457142 | Int J Mol Sci | Role of Branched-Chain Amino Acid Metabolism in Type 2 Diabetes, Obesity, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50249 | 35457120 | Int J Mol Sci | PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients. | 2022 | Details |
| A50253 | 35454138 | Biomolecules | Factors Influencing Gallstone Formation: A Review of the Literature. | 2022 | Details |
| A50254 | 35453964 | Diagnostics (Basel) | Association of Non-Alcoholic Fatty Liver Disease and Hepatic Fibrosis with Epicardial Adipose Tissue Volume and Atrial Deformation Mechanics in a Large Asian Population Free from Clinical Heart Failure. | 2022 | Details |
| A50267 | 35449229 | Sci Rep | Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD. | 2022 | Details |
| A50283 | 35443534 | J Assoc Physicians India | Correlation Between Carotid Intima Media Thickness and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50286 | 35443470 | J Assoc Physicians India | A Study of Correlation between Non Alcoholic Fatty Liver Disease and Carotid Atherosclerosis. | 2022 | Details |
| A50288 | 35443385 | J Assoc Physicians India | A Study of Left Ventricular Dysfunction in Normotensive Non Diabetic Patients with Non Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50289 | 35443336 | J Assoc Physicians India | Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Morbidity in Polycystic Ovarian Syndrome. | 2022 | Details |
| A50298 | 35439567 | J Hepatol | Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial. | 2022 | Details |
| A50304 | 35437952 | EMBO Mol Med | When fat meets the gut-focus on intestinal lipid handling in metabolic health and disease. | 2022 | Details |
| A50314 | 35436057 | Egypt J Immunol | Role of Thymosin Beta 4 in the diagnosis of Nonalcoholic Fatty Liver and its relation to Metabolic Syndrome in Egyptian patients. | 2022 | Details |
| A50333 | 35430032 | Lancet Gastroenterol Hepatol | The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas. | 2022 | Details |
| A50334 | 35430025 | J Clin Lipidol | JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk. | 2022 | Details |
| A50335 | 35429980 | Cardiovasc Diabetol | The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study. | 2022 | Details |
| A50336 | 35429258 | Cardiovasc Toxicol | Interplay of Obesity, Ethanol, and Contaminant Mixture on Clinical Profiles of Cardiovascular and Metabolic Diseases: Evidence from an Animal Study. | 2022 | Details |